Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Human Stem Cells Institute to develop ischemia drug in U.S. and Canada
Thursday, October 13, 2016Human Stem Cells Institute Says it has licensed the exclusive US and Canadian rights for Neovasculgen to ArtGen Inc a privately held biotechnology company located in Rockville MD Neovasculgen is a firstinclass gene therapy drug that was approved in...
Synairgen slumps by a third as AstraZeneca ditches asthma drug study
Thursday, October 13, 2016Synairgen Plc said its partner AstraZeneca Plc stopped a midstage study for testing Synairgens drug candidate as a potential treatment for severe asthma putting the brakes on the lead product in Synairgens pipeline The drug developers shares slumped...
RXi Pharmaceuticals enters into exclusive option agreement to acquire Mirimmune Inc
Thursday, October 13, 2016RXi Pharmaceuticals enters into exclusive option agreement to acquire Mirimmune Inc RXi Pharmaceuticals Corp can exercise option to acquire Mirimmune on terms set forth in option agreement at any time prior to April RXi Pharmaceuticals Corp deal...
Addex Therapeutics initiates new study with US National Institute of Drug Abuse
Wednesday, October 12, 2016Addex initiates new study in collaboration with US National Institute of Drug Abuse with ADX in nonhuman primate model of cocaine addiction Study is being conducted through companys ongoing research collaboration with US national institute of drug a...
Allergan says FDA accepts supplemental new drug application for avycaz
Wednesday, October 12, 2016FDA accepts supplemental new drug application SNDA for avycaz ceftazidime and avibactam Allergan plc FDA is expected to take action on filing in q of Allergan application seeks to expand avycaz label to include phase clinical data for treatment...
Ablynx Extends Ion Channel Research Collaboration With Merck & Co., Inc.
Wednesday, October 12, 2016Ablynx announced a second extension of its research collaboration with a subsidiary of Merck Co Inc Kenilworth NJ USA known as MSD outside the United States and Canada to develop and commercialise Nanobody candidates directed towards an undisclosed...
France opens its first supervised injection center for drug users
Wednesday, October 12, 2016France inaugurated its first supervised injection facility for drug users on Tuesday setting aside years of acrimonious debate over the merits of a strategy that has slowly gained traction since the Swiss embraced it three decades ago Frances Social...
Innate Pharma announced data for two Phase I studies for lirilumab and nivolumab
Monday, October 10, 2016Innate Pharma SA Announced on Sunday safety data for two Phase I studies conducted by BristolMyers Squibb Combination of lirilumab and nivolumab in Phase I study of advanced solid tumors showed no added toxicity over nivolumab monotherapy Data suppo...
Exelixis and Pfizer drugs face off in kidney cancer
Monday, October 10, 2016Exelixis drug Cabometyx beat Pfizers Sutent in a clinical study in metastatic kidney cancer suggesting it has the potential to become a firstline treatment researchers said on Monday The drug is currently approved only in patients who have already r...
Mylan to pay $465 million over EpiPen Medicaid rebate dispute
Saturday, October 08, 2016Mylan NV MYLO on Friday said it will pay million to settle questions of whether it underpaid US government healthcare programs by misclassifying its EpiPen emergency allergy treatment which has come under intense scrutiny after a series of drastic p...
